المؤلفون: Center for Cell and Gene Therapy, Baylor College of Medicine, The Faris Foundation USA, Stand Up To Cancer, Triumph Over Kid Cancer Foundation, St. Baldrick's Foundation, National Cancer Institute (NCI)

المساهمون: Meenakshi Hegde, M.D., Associate Professor

المصدر: Phase I Study of HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma (HEROS 3.0)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04995003Test

Other URLs: https://rarediseases.info.nih.govTest/

المصدر: Klhsky M, Ruella M, Shestova O, Lu XM, Best A, Zeeman M, Schmrer M, Gabruswz K, Anderson NR, Petty NE, Cumms KD, Shen F, Shan X, Vel K, Blouch K, Yasho-OhtanY, Kendern SS, K MY, O'Connor RS, Wallace SR, KozlowskMS, Marchne DM, Shestov M, Garc BA, June CH, Gl S. Human cher anten receptor macrophages for cancer munotherapy. Nat Btechnol. 2020 Aug;38(8):947-953. do 10.1038/s41587-020-0462-y. Epub 2020 Mar 23.
A Phase 1, First in Human Study of Adenovirally Transduced Autologous Macrophages Engineered to Contain an Anti-HER2 Chimeric Antigen Receptor in Subjects With HER2 Overexpressing Solid Tumors

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04660929Test